相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Initial Prostate Health Index (phi) and phi density predicts future risk of clinically significant prostate cancer in men with initial negative prostate biopsy: a 6-year follow-up study
Alex Qinyang Liu et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2022)
Prospective assessment of two-gene urinary test with multiparametric magnetic resonance imaging of the prostate for men undergoing primary prostate biopsy
Gian Maria Busetto et al.
WORLD JOURNAL OF UROLOGY (2021)
PHI density prospectively improves prostate cancer detection
Carsten Stephan et al.
WORLD JOURNAL OF UROLOGY (2021)
The prostate health index (PHI) density: Are there advantages over PHI or over the prostate-specific antigen density?
Manuel M. Garrido et al.
CLINICA CHIMICA ACTA (2021)
MRI-targeted or systematic biopsies in prostate cancer screening: The STHLM3MRI trial
M. Eklund et al.
EUROPEAN UROLOGY (2021)
Comparison of PHI and PHI Density for Prostate Cancer Detection in a Large Retrospective Caucasian Cohort
Robert Peters et al.
UROLOGIA INTERNATIONALIS (2021)
Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database
Ugo Giovanni Falagario et al.
EUROPEAN UROLOGY ONCOLOGY (2021)
Noninvasive Detection of Clinically Significant Prostate Cancer Using Circulating Tumor Cells
Lei Xu et al.
JOURNAL OF UROLOGY (2020)
Combining prostate health index and multiparametric magnetic resonance imaging in the diagnosis of clinically significant prostate cancer in an Asian population
Po-Fan Hsieh et al.
WORLD JOURNAL OF UROLOGY (2020)
Beyond PSA: The Role of Prostate Health Index (phi)
Matteo Ferro et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Preoperative %p2PSA and Prostate Health Index Predict Pathological Outcomes in Patients with Prostate Cancer Undergoing Radical Prostatectomy
Yung-Ting Cheng et al.
SCIENTIFIC REPORTS (2020)
Clinical utility and cost modelling of the phi test to triage referrals into image-based diagnostic services for suspected prostate cancer: the PRIM (Phi to RefIne Mri) study
Lois Kim et al.
BMC MEDICINE (2020)
Effects of real life prostate MRI inter-observer variability on total needle samples and indication for biopsy
Barak Rosenzweig et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2020)
Prostate Health Index and Prostate Health Index Density as Diagnostic Tools for Improved Prostate Cancer Detection
Marija Barisiene et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Update on Circulating Tumor Cells in Genitourinary Tumors with Focus on Prostate Cancer
Alessia Cimadamore et al.
CELLS (2020)
Genomic Analysis of Localized High-Risk Prostate Cancer Circulating Tumor Cells at the Single-Cell Level
Aline Rangel-Pozzo et al.
CELLS (2020)
The cost-effectiveness of prostate health index for prostate cancer detection in Chinese men
Jeremy Yuen-Chun Teoh et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2020)
Association between PSA density and pathologically significant prostate cancer: The impact of prostate volume
Nativ Omri et al.
PROSTATE (2020)
Cost-Effectiveness Analysis of Prostate Health Index in Decision Making for Initial Prostate Biopsy
Da Huang et al.
FRONTIERS IN ONCOLOGY (2020)
Use of the Prostate Health Index and Density in 3 Outpatient Centers to Avoid Unnecessary Prostate Biopsies
Anni Schulze et al.
UROLOGIA INTERNATIONALIS (2020)
Prebiopsy IMPROD Biparametric Magnetic Resonance Imaging Combined with Prostate-Specific Antigen Density in the Diagnosis of Prostate Cancer: An External Validation Study
Juha Knaapila et al.
EUROPEAN UROLOGY ONCOLOGY (2020)
The application of p2PSA% and prostate health index in prostate cancer detection: A prospective cohort in a Tertiary Medical Center
Yung-Ting Cheng et al.
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION (2019)
The Utility of Prostate Specific Antigen Density, Prostate Health Index, and Prostate Health Index Density in Predicting Positive Prostate Biopsy Outcome is Dependent on the Prostate Biopsy Methods
Camila Lopes Vendrami et al.
UROLOGY (2019)
Prediction Medicine: Biomarkers, Risk Calculators and Magnetic Resonance Imaging as Risk Stratification Tools in Prostate Cancer Diagnosis
Daniel F. Osses et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Circulating Tumor Cells Identify Patients with Super-High-Risk Non-Muscle-Invasive Bladder Cancer: Updated Outcome Analysis of a Prospective Single-Center Trial
Chiara Nicolazzo et al.
ONCOLOGIST (2019)
Economic evaluation of the introduction of the Prostate Health Index as a rule-out test to avoid unnecessary biopsies in men with prostate specific antigen levels of 4-10 in Hong Kong
Janet Bouttell et al.
PLOS ONE (2019)
Prostate health index density predicts aggressive pathological outcomes after radical prostatectomy in Taiwanese patients
Yu-Pin Huang et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2019)
A Multicentre Evaluation of the Role of the Prostate Health Index (PHI) in Regions with Differing Prevalence of Prostate Cancer: Adjustment of PHI Reference Ranges is Needed for European and Asian Settings
Peter K-F Chiu et al.
EUROPEAN UROLOGY (2019)
Head-to-head Comparison of Transrectal Ultrasound-guided Prostate Biopsy Versus Multiparametric Prostate Resonance Imaging with Subsequent Magnetic Resonance-guided Biopsy in Biopsy-naive Men with Elevated Prostate-specific Antigen: A Large Prospective Multicenter Clinical Study
Marloes van der Leest et al.
EUROPEAN UROLOGY (2019)
Prebiopsy Biparametric Magnetic Resonance Imaging Combined with Prostate-specific Antigen Density in Detecting and Ruling out Gleason 7-10 Prostate Cancer in Biopsy-naive Men
Lars Boesen et al.
EUROPEAN UROLOGY ONCOLOGY (2019)
Combining Prostate Health Index density, magnetic resonance imaging and prior negative biopsy status to improve the detection of clinically significant prostate cancer
Sasha C. Druskin et al.
BJU INTERNATIONAL (2018)
Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality The CAP Randomized Clinical Trial
Richard M. Martin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2018)
NCCN Guidelines Updates: Prostate Cancer and Prostate Cancer Early Detection
Peter H. Carroll et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2018)
Prospective performance of the Prostate Health Index in prostate cancer detection in the first prostate biopsy of men with a total prostatic specific antigen of 4-10 ng/mL and negative digital rectal examination
Supon Sriplakich et al.
PROSTATE INTERNATIONAL (2018)
Does the Prostate Health Index Depend on Tumor Volume?-A Study on 196 Patients after Radical Prostatectomy
Frank Friedersdorff et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practice
J. J. Tosoian et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2017)
Prostate Health Index density improves detection of clinically significant prostate cancer
Jeffrey J. Tosoian et al.
BJU INTERNATIONAL (2017)
Performance of the Prostate Health Index in predicting prostate biopsy outcomes among men with a negative digital rectal examination and transrectal ultrasonography
Guo-Peng Yu et al.
ASIAN JOURNAL OF ANDROLOGY (2016)
The Cost-Effectiveness of Prostate Cancer Detection with the Use of Prostate Health Index
Eveline A. M. Heijnsdijk et al.
VALUE IN HEALTH (2016)
Preoperative Prostate-specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer: Results from a Multicentric European Prospective Study
Nicola Fossati et al.
EUROPEAN UROLOGY (2015)
The Prostate Health Index Selectively Identifies Clinically Significant Prostate Cancer
Stacy Loeb et al.
JOURNAL OF UROLOGY (2015)
Mortality and complications after prostate biopsy in the Prostate, Lung, Colorectal and Ovarian Cancer Screening (PLCO) trial
Paul F. Pinsky et al.
BJU INTERNATIONAL (2014)
The influence of prostate volume in prostate health index performance in patients with total PSA lower than 10 μg/L
Xavier Filella et al.
CLINICA CHIMICA ACTA (2014)
Overdiagnosis and Overtreatment of Prostate Cancer
Stacy Loeb et al.
EUROPEAN UROLOGY (2014)
Multicenter European External Validation of a Prostate Health Index-based Nomogram for Predicting Prostate Cancer at Extended Biopsy
Giovanni Lughezzani et al.
EUROPEAN UROLOGY (2014)
The Roles of Multiparametric Magnetic Resonance Imaging, PCA3 and Prostate Health Index-Which is the Best Predictor of Prostate Cancer after a Negative Biopsy?
Francesco Porpiglia et al.
JOURNAL OF UROLOGY (2014)
Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up
Fritz H. Schroder et al.
LANCET (2014)
Serum Isoform [-2]proPSA Derivatives Significantly Improve Prediction of Prostate Cancer at Initial Biopsy in a Total PSA Range of 2-10 ng/ml: A Multicentric European Study
Massimo Lazzeri et al.
EUROPEAN UROLOGY (2013)
Cost-effectiveness of Prostate Health Index for prostate cancer detection
Michael B. Nichol et al.
BJU INTERNATIONAL (2012)
Prostate-Specific Antigen (PSA) Isoform p2PSA Significantly Improves the Prediction of Prostate Cancer at Initial Extended Prostate Biopsies in Patients with Total PSA Between 2.0 and 10 ng/ml: Results of a Prospective Study in a Clinical Setting
Giorgio Guazzoni et al.
EUROPEAN UROLOGY (2011)
Prostate-Specific Antigen (PSA) Isoform p2PSA in Combination with Total PSA and Free PSA Improves Diagnostic Accuracy in Prostate Cancer Detection
Flip H. Jansen et al.
EUROPEAN UROLOGY (2010)
[-2]Proenzyme Prostate Specific Antigen is More Accurate Than Total and Free Prostate Specific Antigen in Differentiating Prostate Cancer From Benign Disease in a Prospective Prostate Cancer Screening Study
Brian V. Le et al.
JOURNAL OF UROLOGY (2010)
The performance of prostate specific antigen, prostate specific antigen density and transition zone density in the era of extended biopsy schemes
Christopher S. Elliott et al.
JOURNAL OF UROLOGY (2008)
Decision curve analysis: A novel method for evaluating prediction models
Andrew J. Vickers et al.
MEDICAL DECISION MAKING (2006)
Prostate volume and prostate-specific antigen levels in men enrolled in a large screening trial
Paul F. Pinsky et al.
UROLOGY (2006)
The ratio of prostate-specific antigen (PSA) to prostate volume (PSA density) as a parameter to improve the detection of prostate carcinoma in PSA values in the range of < 4 ng/mL
C Stephan et al.
CANCER (2005)
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
JI Epstein et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
分享论文
